Article
A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia - 1 May 2015
Thuy Matthew N T, Kam Jeremy K T, Lee Geoffrey C Y, Tao Peter L, Ling Dorothy Q, Cheng Melissa, Goh Su Kah, Papachristos Alexander J, Shukla Lipi, Wall Krystal-Leigh, Smoll Nicolas R, Jones Jordan J, Gikenye Njeri, Soh Bob, Moffat Brad, Johnson Nick, Drummond Katharine J
Abstract excerpt
Glioblastoma multiforme (GBM) has a poor prognosis despite maximal multimodal therapy. Biomarkers of relevance to prognosis which may also identify treatment targets are needed. A few hundred genetic and molecular predictors have been implicated in the literature, however with the exception of IDH1 and O6-MGMT, there is uncertainty regarding their true prognostic relevance. This study analyses reported genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
